课题基金 / 基金详情

SFB 807: Transport and Communication across Biological Membrans

SFB 807: Transport and Communication across Biological Membrans
SFB 807:跨生物膜的运输和通讯
批准号:
57566863
负责人:
金额:
$0.0万
依托单位国家:
德国
项目类别:
Collaborative Research Centres
财政年份:
2008
资助国家:
德国
项目状态:
已结题
起止时间:
2007-12-31 至 2019-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Biological membranes are intimately associated with the evolution of life, providing a barrier to or within the cell that allows for compartmentalisation and structure formation as well as concentration of molecules. However, any living cell has to communicate via this barrier with its environment and, therefore, membranes are equipped with a multitude of membrane proteins that are required for uptake and export of molecules and for communication across this barrier (sensing of stimuli and signal transduction to intracellular targets). This pivotal role of membrane proteins is exemplified in genomes from all kingdoms of life, in which 25-30 percent of the genetic information encodes for membrane proteins. Despite their importance for the physiology of cells, a precise understanding of membrane proteins and processes are only rarely available. In particular, transport processes and information transfer are often not well resolved, even though they are of paramount interest from a biomedical standpoint of view as reflected by the fact that roughly 60 percent of the currently used medical drugs target transmembrane processes. This discrepancy between our knowledge and the importance of transmembrane processes will ensure that this research area will stay in the focus both of academic research as well as the pharmaceutical industry for years to come. The Collaborative Research Centre is designed to be a comprehensive multidisciplinary approach to study the principles and molecular mechanisms of transport of molecules and information across membranes in different cellular systems and subcellular compartments. The consortium combines a large set of biochemical, biophysical, cell and structural biological as well as computational approaches to elucidate these processes in molecular detail. This entails the determination of the chronological order of key events during a transfer cycle, their timescales and their structural bases. In particular, the presumed ability of transporters and receptors to adopt multiple conformations, which are required for completion of a full activity cycle, requires the identification of these essential conformational states and an understanding of how interchange between them occurs. We will address how these events are integrated into macromolecular complexes and signalling networks by analysing their crosstalk with other membrane proteins as well as with intra- and extracellular factors.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1073/pnas.1303333110
发表时间: 2013-05-07
期刊: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子: 11.1
作者: [Preiss, Laura, Klyszejko, Adriana L., Meier, Thomas]
通讯作者: Meier, Thomas
DOI: 10.1073/pnas.1817665116
发表时间: 2019-04
期刊: Proceedings of the National Academy of Sciences
影响因子: --
作者: [Jakob Maciejko;J. Kaur;Johanna Becker‐Baldus;C. Glaubitz]
通讯作者: Jakob Maciejko;J. Kaur;Johanna Becker‐Baldus;C. Glaubitz
DOI: 10.1021/ja400554y
发表时间: 2013-05
期刊: Journal of the American Chemical Society
影响因子: 15
作者: [Mirka Neumann-Verhoefen;Karsten Neumann;C. Bamann;I. Radu;J. Heberle;E. Bamberg;J. Wachtveitl]
通讯作者: Mirka Neumann-Verhoefen;Karsten Neumann;C. Bamann;I. Radu;J. Heberle;E. Bamberg;J. Wachtveitl
DOI: 10.1038/nature11403
发表时间: 2012-10-04
期刊: NATURE
影响因子: 64.8
作者: [Perez, Camilo, Koshy, Caroline, Ziegler, Christine]
通讯作者: Ziegler, Christine
8
    国内基金
    海外基金
    茯苓β-葡萄糖苷酶WcBGL807理性设计增强大豆苷元生物转化效率的机制与应用基础研究
    • 批准号:
      2026JJ80515
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李洪波
    • 依托单位:
    CRISPR/Cas9修复SMALED患者iPSC中DYNC1H1G807S杂合突变的基础研究
    • 批准号:
      81671117
    • 项目类别:
      面上项目
    • 资助金额:
      57.0万元
    • 批准年份:
      2016
    • 负责人:
      金庆文
    • 依托单位:
    以Hsp90与Akt之间的结合为靶点的新型Akt抑制剂FM807及其抗肿瘤机制
    • 批准号:
      81202561
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2012
    • 负责人:
      叶敏
    • 依托单位: